Market Cap
$220.5M
NUS
NU SKIN ENTERPRISES, INC.
$4.61 ▲ +1.32%
Prev close $4.55Market cap$220.5M
12-mo target$12.77 (+177.0%)
Insider Selling Cluster (2 insiders)High Impact Filing (7/10)16 New Institutional Positions21 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on NUS right now — valuation, ownership and activity at a glance.
Cap Size
Micro Cap
Inst. Holders
50 funds
Inst. Value
$147.8M
Inst. Activity
16 buys / 21 sells
Insider Activity
$0.00 buy / $99.5K sell
Insider Net $
-$99.5K
SEC Reports
4
Price chart 30d -1.9%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 9, 2026 Insider
Aug 11, 2026 SEC WOODBURY EDWINA D was granted 22 shares
Director @ $4.85 ($106.70)
Nu Skin Enterprises reported Q2 2026 adjusted EPS of $0.20, a 37.5% miss vs the $0.32 consensus, on revenue of $320.1M,
8-K — Impact 7/10
Aug 10, 2026 earnings_calendar
NUS Q2 2026 Earnings Scheduled — 2026-08-10
Jun 30, 2026 Inst.
CHARLES SCHWAB INVESTMENT MANAGEMENT — TRIM
1,452,937 shares ($7.7M)
Jun 30, 2026 Inst.
Jun 12, 2026 SEC PRUDENTIAL FINANCIAL INC — DOUBLED
926,287 shares ($4.9M)
A mixed institutional cluster in NUS for Q3 2024 shows 11 buyers adding $7.4M in net new holdings (led by Citadel, D.E.
INST-CLUSTER — Impact 5/10
Jun 10, 2026 Insider
WOODBURY EDWINA D was granted 19 shares
Director @ $5.43 ($103.17)
Jun 2, 2026 Insider
Winett James M sold 7,203 shares
Director @ $5.62 ($40.5K)
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Dec 20, 2024 | DA Davidson | MAINTAIN | Neutral | 53% |
| Oct 22, 2024 | Citigroup | MAINTAIN | Neutral | 55% |
| Aug 12, 2024 | DA Davidson | MAINTAIN | Neutral | 53% |
| Aug 9, 2024 | Citigroup | MAINTAIN | Neutral | 55% |
| May 9, 2024 | DA Davidson | MAINTAIN | Neutral | 53% |
| Jan 5, 2024 | DA Davidson | MAINTAIN | Neutral | 53% |
| Oct 16, 2023 | Stifel | MAINTAIN | Hold | 54% |
| Sep 29, 2023 | Citigroup | MAINTAIN | Neutral | 55% |
| Aug 3, 2023 | DA Davidson | REITERATE | Neutral | 53% |
| Aug 2, 2023 | Stifel | MAINTAIN | Hold | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2025 | 0 | 0 | 3 | 4 | 1 | 0% | |
| May 1, 2025 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Apr 1, 2025 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Mar 1, 2025 | 0 | 0 | 4 | 4 | 1 | 0% |
Price targets
Where 1 covering analysts think NUS trades over the next 12 months.
$12.77 +177.0% upside Strong Buy
Current$4.61 Low$12.77 Median$12.77 High$12.77 1 analysts
$12.77$12.77
Analyst rating None as of Oct 3, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
4 SEC filing reports analyzed · 0 bullish, 2 bearish, 0 mixed, 2 neutral · avg impact 4.3/10.
BEARISH8-K7/10
Nu Skin Enterprises reported Q2 2026 adjusted EPS of $0.20, a 37.5% miss vs the $0.32 consensus, on
Aug 11, 2026
BEARISHINST-CLUSTER5/10
A mixed institutional cluster in NUS for Q3 2024 shows 11 buyers adding $7.4M in net new holdings (l
Jun 12, 2026
NEUTRAL8-K2/10
Nu Skin Enterprises disclosed the resignation of EVP and Chief Product Officer Steven K. Hatchett du
May 8, 2026
NEUTRALDEFA14A3/10
Nu Skin Enterprises is holding its annual shareholder meeting on May 28, 2026, where shareholders wi
Apr 3, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 10, 2026
earnings_calendar
NUS Q2 2026 Earnings Scheduled — 2026-08-10
Jul 31, 2026
short_interest_report
Short Interest: NUS up 11% to 4.6M shares
Settlement 2026-07-31 | Days to cover: 10.00 | ≈9.53% of shares outstanding (est.)
May 7, 2026
earnings_calendar
NUS Q1 2026 Earnings Scheduled — 2026-05-07
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.21 | $0.21–$0.21 | -38.2% | -34.4% | 0↑ 1↓ | $0.3B | 1 |
| Next Q | $0.27 | $0.27–$0.27 | -6.9% | -22.9% | 0↑ 1↓ | $0.3B | 1 |
| Current FY | $0.82 | $0.82–$0.82 | -35.4% | -18.0% | 0↑ 1↓ | $1.3B | 1 |
| Next FY | $1.16 | $1.16–$1.16 | 41.5% | -12.1% | 0↑ 1↓ | $1.5B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.210 | — |
| 7d ago | $0.320 | -0.110 |
| 30d ago | $0.320 | -0.110 |
| 60d ago | $0.320 | -0.110 |
| 90d ago | $0.320 | -0.110 |
Institutional ownership
Which big funds own NUS (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $147.8M total value (28,002,884 shares) as of 2026-Q2. Top holders: BlackRock,, AMERICAN, VANGUARD. Net selling activity: 21 institutions trimmed/exited vs 16 added.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 4,315,878 | $22.8M | 15.4% | — |
| AMERICAN CENTURY COMPANIES INC | 2,301,308 | $12.2M | 8.2% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,049,641 | $10.8M | 7.3% | — |
| DIMENSIONAL FUND ADVISORS LP | 1,796,745 | $9.5M | 6.4% | ADD +26.3% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,736,856 | $9.2M | 6.2% | — |
| RENAISSANCE TECHNOLOGIES LLC | 1,607,692 | $8.5M | 5.7% | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,452,937 | $7.7M | 5.2% | TRIM -32.2% |
| GEODE CAPITAL MANAGEMENT, LLC | 1,269,191 | $6.7M | 4.5% | — |
| TWO SIGMA INVESTMENTS, LP | 1,168,634 | $6.2M | 4.2% | — |
| STATE STREET CORP | 1,009,648 | $5.3M | 3.6% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | TRIM | 2,143,294 | 1,452,937 | -32.2% | $7.7M |
| PRUDENTIAL FINANCIAL INC | DOUBLED | 376,795 | 926,287 | +145.8% | $4.9M |
| CITADEL ADVISORS LLC | DOUBLED | 227,385 | 654,577 | +187.9% | $3.5M |
| FIRST TRUST ADVISORS LP | ADD | 96,857 | 175,302 | +81.0% | $925.6K |
| Russell Investments Group, Ltd. | ADD | 99,275 | 168,189 | +69.4% | $888.0K |
| JPMORGAN CHASE & CO | TRIM | 207,297 | 142,588 | -31.2% | $751.4K |
| LAZARD ASSET MANAGEMENT LLC | TRIM | 330,647 | 137,995 | -58.3% | $728.6K |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | TRIM | 274,963 | 127,056 | -53.8% | $670.9K |
| UBS Group AG | TRIM | 236,025 | 122,629 | -48.0% | $647.5K |
| ExodusPoint Capital Management, LP | ADD | 78,009 | 116,744 | +49.7% | $616.4K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
12 insiders, 33 transactions. Net -$99.5K — $0.00 bought, $99.5K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | WOODBURY EDWINA D | Director | AWARD | 22 | $4.85 | $106.70 |
| Jun 10, 2026 | WOODBURY EDWINA D | Director | AWARD | 19 | $5.43 | $103.17 |
| Jun 2, 2026 | Winett James M | Director | SELL | 7,203 | $5.62 | $40.5K |
| Jun 1, 2026 | CAMPBELL DANIEL W | Director | AWARD | 26,643 | — | — |
| Jun 1, 2026 | Battle Emma S. | Director | AWARD | 26,643 | — | — |
| Jun 1, 2026 | Thomas Pisano R. | Director | AWARD | 26,643 | — | — |
| Jun 1, 2026 | WOODBURY EDWINA D | Director | AWARD | 26,643 | — | — |
| Jun 1, 2026 | Nathanson Laura | Director | AWARD | 26,643 | — | — |
| Jun 1, 2026 | WOODBURY EDWINA D | Director | SELL | 7,203 | $5.70 | $41.1K |
| Jun 1, 2026 | Zorko Mark A | Director | AWARD | 26,643 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for NUS.
Shares short
4,767,898
Settlement Sep 15, 2026
Change vs prior
+5.4%
Semi-monthly cycle
Days to cover
8.8
At avg daily volume
Of shares outstanding
≈9.8%
Estimate — not % of float
All NUS filing & press-release reports (4)
- 8-K reportAug 11, 2026
- INST-CLUSTER reportJun 12, 2026
- 8-K reportMay 8, 2026
- DEFA14A reportApr 3, 2026